Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleLamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsJunyong Park
View all 1
View less